Combined multiple peripheral nerve blocks with laryngeal mask airway anesthesia for total hip arthroplasty in a very high-risk patient: A case report
Main Article Content
Abstract
Total hip arthroplasty in a patient with severe pulmonary hypertension, heart failure, and end-stage renal disease on hemodialysis is a major anesthetic challenge due to the high mortality risk with both standard general anesthesia and neuraxial anesthesia. We report a 64-year-old male (50 kg, ASA IV) with a right femoral neck fracture, left ventricular ejection fraction 31%, right ventricular fractional area change 28%, systolic pulmonary arterial pressure 79 mmHg, and end-stage renal disease on hemodialysis. The patient underwent total hip arthroplasty via a posterolateral approach. The anesthetic strategy strictly avoided neuraxial techniques, substituting them with four ultrasound-guided peripheral nerve blocks (femoral, anterior and posterior obturator, lateral femoral cutaneous, and sacral multifidus plane blocks) using 110 mg of 0.25% ropivacaine mixed with dexamethasone. This was combined with BIS-guided general anesthesia via a laryngeal mask airway, prophylactic noradrenaline, and sugammadex. Intraoperative hemodynamics remained stable. Postoperatively, the patient recovered smoothly, maintaining a Visual Analog Scale (VAS) pain score of 1/10 for 12 hours without requiring supplemental opioids. This approach demonstrates a feasible and safe anesthetic strategy for high-risk patients.
Article Details
Keywords
Total hip arthroplasty, pulmonary hypertension, peripheral nerve block, sacral multifidus plane block, regional anesthesia, case report
References
2. Price LC, Martinez G, Brame A, et al. Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus. Br J Anaesth. 2021;126(4):774-790. https://doi.org/10.1016/j.bja.2021.01.005
3. Dost B, Narayanan M, Marrone F, et al. The Sacral Erector Spinae Plane Block: A Narrative Review. Pain Ther. 2026;15(1):131-147. https://doi.org/10.1007/s40122-025-00807-6
4. Marrone F, Paventi S, Tomei M, et al. Unilateral sacral erector spinae plane block for hip fracture surgery. Anaesth Rep. 2024;12(1):e12269. https://doi.org/10.1002/anr3.12269
5. Pullano C, Iacobone E, Ferrini F, et al. Combination of PENG and Sacral Erector Spinae Plane Blocks for Hip Fracture Pain and Surgery: A Case Series. Cureus. 2024;16(2):e53815.. https://doi.org/10.7759/cureus.53815
6. Niu Z, Xu X, Chu H, Yin J. Anesthetic management of hip fracture in geriatric patient with respiratory and heart failure using pericapsular nerve group block: A case report. Medicine (Baltimore). 2022;101(22):e29317. https://doi.org/10.1097/MD.0000000000029478
7. Karam M, Hatem M, Habbal M, et al. Hip hemiarthroplasty using major lower limb nerve blocks: a preliminary report. Saudi J Anaesth. 2014;8(Suppl 1):S37-S40. https://doi.org/10.4103/1658-354X.136432
8. Diwan S, Garud R, Sancheti P. Deciphering the mechanism of continuous sacral erector spinae block: a cadaveric study. Turk J Anaesthesiol Reanim. 2022;50(6):471-473. https://doi.org/10.5152/TJAR.2022.21294
9. Satici MH, Tutar MS, Tire Y, et al. The effect of sacral erector spinae plane block on the quality of recovery after total hip arthroplasty: a prospective, randomized, controlled, multicenter study. Minerva Anestesiol. 2025;91(4):278-285. https://doi.org/10.23736/S0375-9393.24.18353-8
10. Uppal NN, Jhaveri M, Hong S, et al. Local anesthetics for the Nephrologist. Clin Kidney J. 2022;15(2):186-193. https://doi.org/10.1093/ckj/sfab121
11. Knudsen K, Beckman Suurküla M, Blomberg S, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78(5):507-514. https://doi.org/10.1093/bja/78.5.507
12. Pehora C, Pearson AM, Kaushal A, et al. Dexamethasone as an adjuvant to peripheral nerve block. Cochrane Database Syst Rev. 2017;11(11):CD011770. https://doi.org/10.1002/14651858.CD011770.pub2
13. de Souza CM, Tardelli MA, Tedesco H, et al. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with ESRD: A prospective clinical trial. Eur J Anaesthesiol. 2015;32(10):681-686. https://doi.org/10.1097/EJA.0000000000000312
14. Cammu G, De Kam PJ, Demeyer I, et al. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment. Br J Anaesth. 2012;109(3):382-390. https://doi.org/10.1093/bja/aes207